• Home
  • Covid-19
  • Tools
    • Introduction to the Tools
    • Model Government Use Licences
    • Model Uses of Paragraph 7 or “LDC Waiver”
    • Special Compulsory Licences for Export of Medicines
    • Options for Regional Economic Communities
    • Voluntary Licences
  • TRIPS Flexibilities Database
  • Resources
    • Briefs & Briefing Documents
    • Publications
    • Tools
    • Useful Links
    • All Resources
  • Blog
  • About
Search
Medicines Law & Policy Research and resources on intellectual property and health
  • Home
  • Covid-19
  • Tools
    • Introduction to the Tools
    • Model Government Use Licences
    • Model Uses of Paragraph 7 or “LDC Waiver”
    • Special Compulsory Licences for Export of Medicines
    • Options for Regional Economic Communities
    • Voluntary Licences
  • TRIPS Flexibilities Database
  • Resources
    • Briefs & Briefing Documents
    • Publications
    • Tools
    • Useful Links
    • All Resources
  • Blog
  • About

Ellen 't Hoen

57 POSTS 0 COMMENTS
http://medicineslawandpolicy.org

Covid shows the world it needs new rules to deal with pandemics

Ellen 't Hoen - May 21, 2021

Dutch Health Care Institute Says No to Medicines Pirate

Ellen 't Hoen - March 29, 2021

The elephant in the room at the WHO Executive Board

Ellen 't Hoen - January 22, 2021

Some Surprises in the European Commission’s New Intellectual Property Strategy

Ellen 't Hoen - December 2, 2020

Dutch Court Orders AstraZeneca to Pay Damages in Patent Evergreening Case

Ellen 't Hoen - October 14, 2020

WTO Members discuss proposal to suspend certain intellectual property protection during the Covid-19 crisis

Ellen 't Hoen - October 14, 2020

TRIPS Council to discuss IP and the public interest in the context of Covid-19

Ellen 't Hoen - July 29, 2020

Remdesivir developed country price announced

Ellen 't Hoen - June 30, 2020

The € 7.4 billion for Covid-19 product and vaccine development needs a few strings...

Ellen 't Hoen - May 5, 2020

Covid-19 intellectual property pool gaining support

Ellen 't Hoen - April 23, 2020
123...6Page 2 of 6
Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: office@medicineslawandpolicy.net.
  • Home
  • Covid-19
  • Tools
    • Introduction to the Tools
    • Model Government Use Licences
    • Model Uses of Paragraph 7 or “LDC Waiver”
    • Special Compulsory Licences for Export of Medicines
    • Options for Regional Economic Communities
    • Voluntary Licences
  • TRIPS Flexibilities Database
  • Resources
    • Briefs & Briefing Documents
    • Publications
    • Tools
    • Useful Links
    • All Resources
  • Blog
  • About
 This work is licensed under Creative Commons.